Works about RITUXIMAB

Results: 5000

Assessment of Efficacy of Adjuvant Topical Rituximab Encapsulated in Nanoparticle Gel in Oral Pemphigus Vulgaris: A Randomized, Double-Blind, Placebo-Controlled, Pilot Study.

Published in:

2025

By:

Mohta, Pratik Rajendra;
Khandpur, Sujay;
Dinda, Amit Kumar;
Bhat, Madhusudan;
Tyagi, Seema;
Sharma, Vinod Kumar;
Kalaivani, Mani

Publication type:

Case Study

Experience of Using a Bruton Tyrosine Kinase (BTK) Inhibitor in Primary Testicular Diffuse Large B-Cell Lymphoma (DLBCL) with Isolated Central Nervous System (CNS) Metastasis.

Published in:

Journal of Clinical Practice & Research, 2025, v. 47, n. 3, p. 328, doi. 10.14744/cpr.2025.96241

By:

Meedimale, Santhosh;
Panda, Soumya Surath;
Panda, Adya Kinkar;
Mohapatra, Debahuti;
Bhola, Rajesh Kumar;
Moharana, Lalatendu;
Mohanty, Swati Sucharita;
Samantaray, Lipsita

Publication type:

Article

Temporal changes of the life and renal prognoses of patients with rapidly progressive glomerulonephritis in Japan, 1989–2019.

Published in:

Clinical & Experimental Nephrology, 2025, v. 29, n. 7, p. 937, doi. 10.1007/s10157-025-02643-6

By:

Nakajima, Kentaro;
Kaneko, Shuzo;
Usui, Joichi;
Tsuboi, Naotake;
Sugiyama, Hitoshi;
Maruyama, Shoichi;
Isaka, Yoshitaka;
Narita, Ichiei;
Yamagata, Kunihiro

Publication type:

Article

A Possible Association between Deep Molecular Response and Combination of Tyrosine Kinase Inhibitor and Immunochemotherapy in a Patient with Coexisting Chronic Myeloid Leukemia and Follicular Lymphoma: A Case Report.

Published in:

Journal of Cancer Research & Practice, 2025, v. 12, n. 2, p. 53, doi. 10.4103/ejcrp.eJCRP-D-25-00009

By:

Tsai, Wen-Yung;
Huang, Cih-En

Publication type:

Article

Rituximab to Prevent Relapse in Anti-NMDAR Antibody-Mediated Encephalitis.

Published in:: Neurology Alert, 2025, v. 44, n. 11, p. 1
Publication type:: Article

Medicare spending and use of subcutaneous biologic formulations with hyaluronidase.

Published in:

Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf149

By:

Kim, John;
Kesselheim, Aaron S;
Cliff, Edward R Scheffer;
Rome, Benjamin N

Publication type:

Article

Real-World Evidence Assessing the Safety of Administering Intravenous Rituximab Biosimilar in the First Cycle and Subcutaneous Rituximab in Subsequent Cycles in B-Cell Lymphoma Patients.

Published in:

Pharmacy, 2025, v. 13, n. 3, p. 83, doi. 10.3390/pharmacy13030083

By:

Almandeel, Tamather;
Khan, Mansoor Ahmed;
Algethami, Ashwag;
Alaboud, Mashael S.;
Alkathiri, Munirah A.;
Aseeri, Mohammed;
Absi, Ahmed;
Almansour, Mubarak;
Alotaibi, Abdullah

Publication type:

Article

Unfolding the Mysteries of Cell-based Human Leukocyte Antigen Crossmatching in Solid Organ Transplantation.

Published in:

Indian Journal of Transplantation, 2025, v. 19, n. 2, p. 125, doi. 10.4103/ijot.ijot_128_24

By:

Tapiawala, Shruti;
Jogale, Suchita;
Danielle, Dolly;
Handoo, Anil

Publication type:

Article

Characterization of anti-canine CD20 antibody 4E1-7-B_f and comparison with commercially available anti-human CD20 antibodies.

Published in:

PLoS ONE, 2025, v. 20, n. 6, p. 1, doi. 10.1371/journal.pone.0325526

By:

Mizuno, Takuya;
Kato, Yukinari;
Tsukui, Toshihiro;
Igase, Masaya

Publication type:

Article

精准给药策略联合预见性护理在接受 R-EPOCH方案治疗的非霍奇金淋巴瘤病人中的应用

Published in:

Chinese Nursing Research, 2024, v. 38, n. 2, p. 349, doi. 10.12102/j.issn.1009-6493.2024.02.028

By:

牛润花;
杨佳;
赵新娜;
郝晓丽

Publication type:

Article

Tratamiento de la encefalopatía mioclónica de la infancia (síndrome de Kinsbourne) con metotrexate y gammaglobulina endovenosa.

Published in:

Acta Pediatrica de Mexico, 2013, v. 34, n. 6, p. 370

By:

Torres Mayagoitia, Dessireé;
Dávila Gutiérrez, Guillermo;
Hernández Bautista, Víctor Manuel;
Vázquez Estrada, Patricia;
Rodríguez Tapia, Jazmín

Publication type:

Article

A simplified protocol using rituximab and immunoglobulin for ABO‐incompatible low‐titre living donor liver transplantation.

Published in:

Liver International, 2018, v. 38, n. 5, p. 932, doi. 10.1111/liv.13614

By:

Kim, Seong Hoon;
Lee, Eung Chang;
Shim, Jae Ryong;
Park, Sang Jae

Publication type:

Article

HCV/HBV coinfection: The dark side of DAAs treatment?

Published in:

Liver International, 2017, v. 37, n. 7, p. 1086, doi. 10.1111/liv.13342

By:

Madonia, Salvatore;
Orlando, Emanuele;
Madonia, Giorgio;
Cannizzaro, Marco

Publication type:

Article

HCV-associated B-cell non- Hodgkin lymphomas and new direct antiviral agents.

Published in:

Liver International, 2015, v. 35, n. 10, p. 2222, doi. 10.1111/liv.12897

By:

Carrier, Paul;
Jaccard, Arnaud;
Jacques, Jérémie;
Tabouret, Tessa;
Debette ‐ Gratien, Marilyne;
Abraham, Julie;
Mesturoux, Laura;
Marquet, Pierre;
Alain, Sophie;
Sautereau, Denis;
Essig, Marie;
Loustaud ‐ Ratti, Véronique

Publication type:

Article

Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.

Published in:

Liver International, 2011, v. 31, n. 3, p. 330, doi. 10.1111/j.1478-3231.2010.02332.x

By:

Méndez-Navarro, Jorge;
Corey, Kathleen E.;
Hui Zheng;
Barlow, Lydia L.;
Jang, Jae Young;
Wenyu Lin;
Hong Zhao;
Run-Xuan Shao;
McAfee, Steven L.;
Chung, Raymond T.

Publication type:

Article

Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma is not rare in Japanese patients with past hepatitis B virus infection.

Published in:

Liver International, 2011, v. 31, n. 3, p. 340, doi. 10.1111/j.1478-3231.2010.02417.x

By:

Watanabe, Masaaki;
Shibuya, Akitaka;
Tsunoda, Yuhko;
Danbara, Mikio;
Ishii, Ryuji;
Ohsaka, Manabu;
Takada, Juichi;
Tanaka, Yoshiaki;
Okuwaki, Yusuke;
Minamino, Tsutomu;
Hidaka, Hisashi;
Nakazawa, Takahide;
Horie, Ryouichi;
Higashihara, Masaaki;
Koizumi, Wasaburo

Publication type:

Article

Hepatitis B re-activation with rituximab therapy: treat the patient not the disease.

Published in:

2011

By:

Zachou, Kalliopi;
Dalekos, George N.

Publication type:

Editorial

Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.

Published in:

Liver International, 2006, v. 26, n. 5, p. 625, doi. 10.1111/j.1478-3231.2006.01262.x

By:

Santos, Edgardo S.;
Arosemena, Leopoldo R.;
Raez, Luis E.;
O'Brien, Christopher;
Regev, Arie

Publication type:

Article

In Situ Evaluation of the Anticancer Antibody Rituximab-dsDNA Interaction Using a DNA-Electrochemical Biosensor.

Published in:

Electroanalysis, 2014, v. 26, n. 6, p. 1304, doi. 10.1002/elan.201300488

By:

Santarino, Inês B.;
Oliveira, Severino Carlos B.;
Oliveira‐Brett, Ana Maria

Publication type:

Article

Disseminated Cryptococcosis in a Non-Hodgkin's Lymphoma Patient with Late-Onset Neutropenia Following Rituximab-CHOP Chemotherapy: A Case Report and Literature Review.

Published in:

Mycopathologia, 2011, v. 172, n. 3, p. 227, doi. 10.1007/s11046-011-9423-9

By:

Hirai, Yuji;
Ainoda, Yusuke;
Shoji, Takayo;
Fujita, Takahiro;
Yoshinaga, Kentaro;
Shiseki, Masayuki;
Mori, Naoki;
Teramura, Masanao;
Totsuka, Kyoichi;
Motoji, Toshiko

Publication type:

Article

Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma.

Published in:

Journal of Neuro-Oncology, 2020, v. 147, n. 1, p. 171, doi. 10.1007/s11060-020-03411-0

By:

Ambady, Prakash;
Fu, Rongwei;
Szidonya, Laszlo;
Peereboom, David M.;
Doolittle, Nancy D.;
Neuwelt, Edward A.

Publication type:

Article

White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab.

Published in:

Journal of Neuro-Oncology, 2019, v. 145, n. 3, p. 461, doi. 10.1007/s11060-019-03279-9

By:

Estephan, Fayez;
Ye, Xiaobu;
Dzaye, Omar;
Wagner-Johnston, Nina;
Swinnen, Lode;
Gladstone, Douglas E.;
Ambinder, Rich;
Kamson, David Olayinka;
Lambrecht, Sebastian;
Grossman, Stuart A.;
Lin, Doris D. M.;
Holdhoff, Matthias

Publication type:

Article

Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study.

Published in:

Journal of Neuro-Oncology, 2017, v. 133, n. 2, p. 315, doi. 10.1007/s11060-017-2435-7

By:

Houillier, Caroline;
Ghesquières, Hervé;
Chabrot, Cécile;
Soussain, Carole;
Ahle, Guido;
Choquet, Sylvain;
Nicolas-Virelizier, Emmanuelle;
Bay, Jacques-Olivier;
Vargaftig, Jacques;
Gaultier, Claude;
Touitou, Valérie;
Martin-Duverneuil, Nadine;
Cassoux, Nathalie;
Garff-Tavernier, Magali;
Costopoulos, Myrto;
Faurie, Pierre;
Hoang-Xuan, Khê

Publication type:

Article

Phosphodiesterase type 5 inhibitor Tadalafil increases Rituximab treatment efficacy in a mouse brain lymphoma model.

Published in:

Journal of Neuro-Oncology, 2015, v. 122, n. 1, p. 35, doi. 10.1007/s11060-014-1690-0

By:

Wang, Rong;
Chen, Wenli;
Zhang, Qiang;
Liu, Yong;
Qiao, Xiaoyun;
Meng, Kui;
Mao, Ying

Publication type:

Article

Treatment of primary CNS lymphoma (PCNSL) following successful treatment of systemic non-Hodgkin's lymphoma (NHL): a case series.

Published in:

Journal of Neuro-Oncology, 2013, v. 113, n. 1, p. 27, doi. 10.1007/s11060-013-1085-7

By:

Chamberlain, Marc

Publication type:

Article

Rituximab significantly improves complete response rate in patients with primary CNS lymphoma.

Published in:

Journal of Neuro-Oncology, 2012, v. 109, n. 2, p. 285, doi. 10.1007/s11060-012-0891-7

By:

Birnbaum, Tobias;
Stadler, Elisabeth;
Baumgarten, Louisa;
Straube, Andreas

Publication type:

Article

Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation.

Published in:

Journal of Neuro-Oncology, 2012, v. 107, n. 2, p. 225, doi. 10.1007/s11060-011-0739-6

By:

Lieberman, Frank;
Yazbeck, Victor;
Raptis, Anastasios;
Felgar, Raymond;
Boyiadzis, Michael

Publication type:

Article

Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.

Published in:

Journal of Neuro-Oncology, 2011, v. 105, n. 2, p. 409, doi. 10.1007/s11060-011-0608-3

By:

Sierra del Rio, Monica;
Choquet, Sylvain;
Hoang-Xuan, Khé;
Glaisner, Sylvie;
Fourme, Emmanuelle;
Janvier, Maud;
Soussain, Carole

Publication type:

Article

High-dose intravenous rituximab for multifocal, monomorphic primary central nervous system posttransplant lymphoproliferative disorder.

Published in:

2011

By:

Patrick, A.;
Wee, A.;
Hedderman, A.;
Wilson, D.;
Weiss, J.;
Govani, M.

Publication type:

Report

Bing–Neel syndrome: an illustrative case and a comprehensive review of the published literature.

Published in:

Journal of Neuro-Oncology, 2010, v. 96, n. 3, p. 301, doi. 10.1007/s11060-009-9968-3

By:

Malkani, Roneil G.;
Tallman, Martin;
Gottardi-Littell, Numa;
Karpus, William;
Marszalek, Laura;
Variakojis, Daina;
Kaden, Bruce;
Walker, Matthew;
Levy, Robert M.;
Raizer, Jeffrey J.

Publication type:

Article

Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstruction.

Published in:

Journal of Neuro-Oncology, 2009, v. 93, n. 3, p. 421, doi. 10.1007/s11060-008-9787-y

By:

Francisco Coret;
Isabel Bosca;
Loren Fratalia;
Jaume Perez-Griera;
Ana Pascual;
Bonaventura Casanova

Publication type:

Article

Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.

Published in:

Journal of Neuro-Oncology, 2009, v. 91, n. 3, p. 271, doi. 10.1007/s11060-008-9707-1

By:

Marc Chamberlain;
Sandra Johnston;
Alixis Van Horn;
Michael Glantz

Publication type:

Article

Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma.

Published in:

Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00518-0

By:

Chen, Ji-Lin;
Chu, Pei-Yi;
Huang, Chun-Teng;
Huang, Tzu-Ting;
Wang, Wan-Lun;
Lee, Yu-Hsuan;
Chang, Yuan-Ya;
Dai, Ming-Shen;
Shiau, Chung-Wai;
Liu, Chun-Yu

Publication type:

Article

Rituximab alleviates increased disomic sperm in DBA/1J mouse models of rheumatoid arthritis via restoration of redox imbalance.

Published in:

Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 12, p. 1, doi. 10.1002/jbt.23496

By:

Attia, Sabry M.;
Al‐Hamamah, Mohammed A.;
Attia, Mohamed S. M.;
Alanazi, Abdulrazaq;
Ahmad, Sheikh F.;
Ansari, Mushtaq A.;
Nadeem, Ahmed;
Bakheet, Saleh A.;
Harisa, Gamaleldin I.

Publication type:

Article

Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases.

Published in:

Clinical Rheumatology, 2023, v. 42, n. 9, p. 2485, doi. 10.1007/s10067-023-06638-0

By:

Oliosi, E.;
Flahault, A.;
Charre, C.;
Veyer, D.;
Combier, A.;
Lafont, E.;
Karras, A.;
Mouthon, L.;
Avouac, J.;
Terrier, B.;
Hadjadj, J.

Publication type:

Article

Predictors of response of rituximab in rheumatoid arthritis by weighted gene co-expression network analysis.

Published in:

Clinical Rheumatology, 2023, v. 42, n. 2, p. 529, doi. 10.1007/s10067-022-06438-y

By:

Zhang, Shan;
Li, Peiting;
Wu, Pengjia;
Yang, Lei;
Liu, Xiaoxia;
Liu, Jun;
Zhang, Yong;
Zeng, Jiashun

Publication type:

Article

Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).

Published in:

2023

By:

Quartuccio, Luca;
Bortoluzzi, Alessandra;
Scirè, Carlo Alberto;
Marangoni, Antonio;
Del Frate, Giulia;
Treppo, Elena;
Castelnovo, Laura;
Saccardo, Francesco;
Zani, Roberta;
Candela, Marco;
Fraticelli, Paolo;
Mazzaro, Cesare;
Renoldi, Piero;
Scaini, Patrizia;
Filippini, Davide Antonio;
Visentini, Marcella;
Scarpato, Salvatore;
Giuggioli, Dilia;
Mascia, Maria Teresa;
Sebastiani, Marco

Publication type:

Correction Notice

Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).

Published in:

Clinical Rheumatology, 2023, v. 42, n. 2, p. 359, doi. 10.1007/s10067-022-06391-w

By:

Quartuccio, Luca;
Bortoluzzi, Alessandra;
Scirè, Carlo Alberto;
Marangoni, Antonio;
Del Frate, Giulia;
Treppo, Elena;
Castelnovo, Laura;
Saccardo, Francesco;
Zani, Roberta;
Candela, Marco;
Fraticelli, Paolo;
Mazzaro, Cesare;
Renoldi, Piero;
Scaini, Patrizia;
Filippini, Davide Antonio;
Visentini, Marcella;
Scarpato, Salvatore;
Giuggioli, Dilia;
Mascia, Maria Teresa;
Sebastiani, Marco

Publication type:

Article

Rituximab treatment in ANCA-associated vasculitis patients: outcomes of a real-life experience from an observational cohort.

Published in:

Clinical Rheumatology, 2022, v. 41, n. 9, p. 2809, doi. 10.1007/s10067-022-06192-1

By:

Carranza-Enríquez, Fabián;
Meade-Aguilar, José Antonio;
Hinojosa-Azaola, Andrea

Publication type:

Article

Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City.

Published in:

Clinical Rheumatology, 2022, v. 41, n. 8, p. 2597, doi. 10.1007/s10067-022-06203-1

By:

Barbhaiya, Medha;
Frey, Marianna B.;
Levine, Jonah;
Vitone, Gregory;
Lally, Lindsay;
Lockshin, Michael D.;
Bykerk, Vivian;
Feldman, Candace H.;
Mandl, Lisa A.

Publication type:

Article

Rituximab as a glucocorticoid-sparing agent in idiopathic inflammatory myopathies: a retrospective single-center cohort study.

Published in:

Clinical Rheumatology, 2022, v. 41, n. 1, p. 123, doi. 10.1007/s10067-021-05871-9

By:

Egeli, Bugra Han;
Ergun, Sercan;
Cetin, Arya;
Gursoy, Yahya Kerem;
Ugurlu, Serdal

Publication type:

Article

A rebuttal letter to the letter ID number CLRH-D-21–00,836 entitled "On the efficacy and safety of rituximab therapy in patients with systemic sclerosis disease: missing points, bottlenecks, over-exaggeration and discrepancies".

Published in:

Clinical Rheumatology, 2021, v. 40, n. 11, p. 4779, doi. 10.1007/s10067-021-05832-2

By:

Moradzadeh, Maliheh;
Aghaei, Mehrdad;
Mehrbakhsh, Zahra;
Arab-Bafrani, Zahra;
Abdollahi, Nafiseh

Publication type:

Article

On the efficacy and safety of rituximab therapy in patients with systemic sclerosis disease: missing points, bottlenecks, over-exaggeration, and discrepancies—comments on the article by Moradzadeh et al.

Published in:

Clinical Rheumatology, 2021, v. 40, n. 10, p. 4365, doi. 10.1007/s10067-021-05786-5

By:

Gkiouras, Konstantinos;
Grammatikopoulou, Maria G.;
Bogdanos, Dimitrios P.

Publication type:

Article

Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis–related interstitial lung diseases: a retrospective, observational cohort study.

Published in:

Clinical Rheumatology, 2021, v. 40, n. 10, p. 4071, doi. 10.1007/s10067-021-05785-6

By:

Yılmaz, Deniz Demir;
Borekci, Sermin;
Musellim, Benan

Publication type:

Article

Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry.

Published in:

Clinical Rheumatology, 2021, v. 40, n. 10, p. 4039, doi. 10.1007/s10067-021-05734-3

By:

Sebastiani, Marco;
Venerito, Vincenzo;
Bugatti, Serena;
Bazzani, Chiara;
Biggioggero, Martina;
Petricca, Luca;
Foti, Rosario;
Bortoluzzi, Alessandra;
Balduzzi, Silvia;
Visalli, Elisa;
Frediani, Bruno;
Manfredi, Andreina;
Gremese, Elisa;
Favalli, Ennio;
Iannone, Florenzo;
Ferraccioli, Gianfranco;
Lapadula, Giovanni;
Contributors;
Galli, Elena;
Cantatore, Francesco Paolo

Publication type:

Article

Efficacy and safety of rituximab therapy in patients with systemic sclerosis disease (SSc): systematic review and meta-analysis.

Published in:

Clinical Rheumatology, 2021, v. 40, n. 10, p. 3897, doi. 10.1007/s10067-021-05698-4

By:

Moradzadeh, Maliheh;
Aghaei, Mehrdad;
Mehrbakhsh, Zahra;
Arab-Bafrani, Zahra;
Abdollahi, Nafiseh

Publication type:

Article

Efficacy and safety of rituximab on lung and skin involvement in systemic sclerosis: a systematic review and metaanalysis.

Published in:

Clinical Rheumatology, 2021, v. 40, n. 7, p. 2779, doi. 10.1007/s10067-020-05542-1

By:

Borrirukwisitsak, Sasimon;
Tantayakom, Pongchirat;
Katchamart, Wanrachada

Publication type:

Article

Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy.

Published in:

Clinical Rheumatology, 2021, v. 40, n. 6, p. 2311, doi. 10.1007/s10067-020-05530-5

By:

Ge, Yongpeng;
Li, Shanshan;
Tian, Xiaolan;
He, Linrong;
Lu, Xin;
Wang, Guochun

Publication type:

Article

Experience with similar biologic rituximab in 77 patients of granulomatosis with polyangiitis—a real-life experience.

Published in:

Clinical Rheumatology, 2021, v. 40, n. 2, p. 645, doi. 10.1007/s10067-020-05261-7

By:

Mittal, Sakshi;
Naidu, G. S. R. S. N. K.;
Jha, Saket;
Rathi, Manish;
Nada, Ritambhra;
Minz, Ranjana W;
Sharma, Kusum;
Dhir, Varun;
Jain, Sanjay;
Sharma, Aman

Publication type:

Article

Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis.

Published in:

Clinical Rheumatology, 2020, v. 39, n. 11, p. 3341, doi. 10.1007/s10067-020-05305-y

By:

Burmester, Gerd;
Drescher, Edit;
Hrycaj, Pawel;
Chien, David;
Pan, Zhiying;
Cohen, Stanley

Publication type:

Article